Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antihistamine |
| gptkbp:approvalYear |
2010
|
| gptkbp:ATCCode |
R06AX29
|
| gptkbp:availableOn |
gptkb:Asia
gptkb:Australia gptkb:Europe |
| gptkbp:CASNumber |
202189-78-4
|
| gptkbp:chemicalFormula |
C28H37N3O3
|
| gptkbp:compatibleWith |
gptkb:United_States
sedative |
| gptkbp:developedBy |
FAES Farma
|
| gptkbp:doesNotCross |
gptkb:blood-brain_barrier
|
| gptkbp:eliminationHalfLife |
14.5 hours
|
| gptkbp:excretion |
urine
feces |
| https://www.w3.org/2000/01/rdf-schema#label |
bilastine
|
| gptkbp:KEGGID |
D08913
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
H1 receptor antagonist
|
| gptkbp:metabolism |
minimal
|
| gptkbp:molecularWeight |
463.6 g/mol
|
| gptkbp:pregnancyCategory |
B3 (Australia)
|
| gptkbp:PubChem_CID |
6918493
CHEMBL2105756 DB06691 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
abdominal pain
dizziness headache drowsiness |
| gptkbp:UNII |
Q1U8A8V977
|
| gptkbp:usedFor |
allergic rhinitis
urticaria |
| gptkbp:bfsParent |
gptkb:R06AX17
|
| gptkbp:bfsLayer |
6
|